PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

4D Pharma Research Limited

USPTO PatentsView assignee record — 49 granted patents across 11 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Explore the portfolio See the ranking
49
Total patents granted
11
CPC technology areas
17.3
Avg claims per patent
+33%
5-year filing velocity

Portfolio overview

4D Pharma Research Limited has been granted 49 US utility patents between 2016 and 2023, placing 4D Pharma Research Limited at rank #6,731 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, 4D Pharma Research Limited is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 38.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 28 grants, compared with 21 in the 2015–2019 window — a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. 4D Pharma Research Limited's 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 4D Pharma Research Limited against peers pursuing similar technology classes.

How does 4D compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows 4D holds 49 patents — placing it at rank #6,731 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2016–2023

051015 20162017201820192020202120222023 1
USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
4D Pharma Research Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 2.0%
2017 3 6.1%
2018 5 10.2%
2019 12 24.5%
2020 7 14.3%
2021 8 16.3%
2022 12 24.5%
2023 1 2.0%

Which technologies does 4D Pharma Research Limited patent most?

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#6,731

Across all tracked assignees

Innovation Score

38.8 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does 4D Pharma Research Limited hold?
4D Pharma Research Limited holds 49 US granted patents filed between 2016 and 2023, spanning 11 technology areas.
What is 4D Pharma Research Limited's Innovation Score?
4D Pharma Research Limited has an Innovation Score of 38.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does 4D Pharma Research Limited focus on?
4D Pharma Research Limited's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 47 patents. The company has filed patents in 11 CPC subclasses total.
Is 4D Pharma Research Limited's patent filing rate increasing or decreasing?
4D Pharma Research Limited's recent filing velocity is +33% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for 4D Pharma Research Limited's patents?
4D Pharma Research Limited's patents average 17.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the 4D Pharma Research Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61P technology

4D Pharma Research Limited's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where 4D Pharma Research Limited ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope